Molecular formula: | C30H34N8 |
Average mass: | 506.658 |
Monoisotopic mass: | 506.290643 |
ChemSpider ID: | 28637805 |
1 of 1 defined stereocentres
0ICW2LX8AS
[UNII]1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N~3~-[(7S)-7-(1-pyrrolidinyl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl]-1H-1,2,4-triazol-3,5-diamin
[German]
[ACD/IUPAC Name]1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N~3~-[(7S)-7-(1-pyrrolidinyl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl]-1H-1,2,4-triazole-3,5-diamine
[ACD/IUPAC Name]1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N~3~-[(7S)-7-(1-pyrrolidinyl)-6,7,8,9-tétrahydro-5H-benzo[7]annulén-2-yl]-1H-1,2,4-triazole-3,5-diamine
[French]
[ACD/IUPAC Name]1037624-75-1
[RN]1H-1,2,4-Triazole-3,5-diamine, 1-(6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N~3~-[(7S)-6,7,8,9-tetrahydro-7-(1-pyrrolidinyl)-5H-benzocyclohepten-2-yl]-
[ACD/Index Name]bemcentinib
[INN]bemcentinib
[French]
[INN]bemcentinib
[Spanish]
[INN]bemcentinibum
[Latin]
[INN]бемцентиниб
[Russian]
[INN]بيمسينتينيب
[Arabic]
[INN](S)-1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-(7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)-1H-1,2,4-triazole-3,5-diamine
1-(6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-[(7S)-6,7,8,9-tetrahydro-7-(1-pyrrolidinyl)-5Hbenzocyclohepten-2-yl]-1H-1,2,4-triazole-3,5-diamine
1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N~3~-[(7S)-7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl]-1H-1,2,4-triazole-3,5-diamine
1H-1,2,4-Triazole-3,5-diamine, 1-(6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-[(7S)-6,7,8,9-tetrahydro-7-(1-pyrrolidinyl)-5H-benzocyclohepten-2-yl]
bemcentinibum
bgb-324;r428
MFCD21608463
[MDL number]r-428(bgb324)
R-428;R 428
R428 (BGB324)
R428 (BGB324; Bemcentinib)
Tyrosine-protein kinase receptor UFO
UFO_HUMAN
бемцентиниб
بيمسينتينيب
贝森替尼
[Chinese]